Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$282.99 - $369.05 $632,765 - $825,195
-2,236 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$242.95 - $284.63 $12,633 - $14,800
52 Added 2.38%
2,236 $626,000
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $10,159 - $15,292
43 Added 2.01%
2,184 $535,000
Q3 2020

Nov 16, 2020

BUY
$264.77 - $305.71 $16,945 - $19,565
64 Added 3.08%
2,141 $607,000
Q2 2020

Aug 12, 2020

SELL
$258.66 - $342.55 $187,269 - $248,006
-724 Reduced 25.85%
2,077 $556,000
Q1 2020

May 14, 2020

SELL
$268.85 - $341.04 $25,271 - $32,057
-94 Reduced 3.25%
2,801 $886,000
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $26,847 - $37,096
-122 Reduced 4.04%
2,895 $859,000
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $20,004 - $22,436
92 Added 3.15%
3,017 $702,000
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $226,526 - $249,696
1,033 Added 54.6%
2,925 $684,000
Q1 2019

Apr 12, 2019

BUY
$216.71 - $338.96 $410,015 - $641,312
1,892 New
1,892 $447,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Shorepoint Capital Partners LLC Portfolio

Follow Shorepoint Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shorepoint Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shorepoint Capital Partners LLC with notifications on news.